STOCK TITAN
  1. Home
  2. Sec-filings
  3. APVO
  4. [EFFECT] Aptevo Therapeutics Inc. SEC Filing

[EFFECT] Aptevo Therapeutics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 25, 2025 4:00 P.M.
Form: S-1
CIK: 0001671584
Company Name: Aptevo Therapeutics Inc.
File Number: 333-290663

Source: View Original Filing on SEC EDGAR

Stock APVO logo
Aptevo Therapeutics Inc

NASDAQ:APVO

APVO Rankings

#6404 Ranked by Market Cap
N/A Ranked by Dividends

APVO Latest News

Jan 9, 2026
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
Dec 26, 2025
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
Dec 9, 2025
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025
Nov 10, 2025
Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors
Nov 6, 2025
Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

APVO Latest SEC Filings

Jan 16, 2026
[PRE 14A] Aptevo Therapeutics Inc. Preliminary Proxy Statement
Jan 9, 2026
[8-K] Aptevo Therapeutics Inc. Reports Material Event
Nov 25, 2025
[424B4] Aptevo Therapeutics Inc. Prospectus Filed Pursuant to Rule 424(b)(4)
Nov 12, 2025
[Form 4] Aptevo Therapeutics Inc. Insider Trading Activity
Nov 6, 2025
[10-Q] Aptevo Therapeutics Inc. Quarterly Earnings Report

APVO Stock Data

8.91M
997.07k
0%
0.48%
3.11%
Biotechnology
Pharmaceutical Preparations
Link
United States
SEATTLE